Characteristics | N | Values |
---|---|---|
Age | 62 | 14.3 (11.9–16.4) |
Sex, male | 62 | 36 (58.1) |
HLA-B27+ | 55 | 31 (56.4) |
Race | 56 | |
White | 46 (82.1) | |
African American | 6 (10.7) | |
Other | 4 (7.1) | |
Active joint count | 52 | 0 (0–1) |
Tender enthesis count | 52 | 0 (0–5) |
Patient-reported pain* | 46 | 4 (1–6) |
Patient-reported disease activity | 45 | 3 (1–5) |
Physician global VAS | 46 | 3 (2–4) |
cJADAS10# | 43 | 6.5 (2–9.7) |
CRP, elevated, ≥ 1 mg/dl | 37 | 19 (51.4) |
ESR, elevated, ≥ 21 mm/h | 41 | 17 (41.5) |
Disease duration, days | 33 | 154 (23–717) |
↵* General pain recorded on VAS.
↵# A validated composite disease measure specifically developed for juvenile idiopathic arthritis and ranges from 0 (inactive disease) to 30, composed of the active joint count (maximum 10 joints), and physician global and parent global disease activity evaluation. VAS: visual analog scale; cJADAS10: Clinical Juvenile Arthritis Disease Activity Score; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; IQR: interquartile range.